Suppr超能文献

前列腺组织的基因表达谱分析表明,染色质调控是肥胖与致命性前列腺癌之间的潜在联系。

Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.

作者信息

Ebot Ericka M, Gerke Travis, Labbé David P, Sinnott Jennifer A, Zadra Giorgia, Rider Jennifer R, Tyekucheva Svitlana, Wilson Kathryn M, Kelly Rachel S, Shui Irene M, Loda Massimo, Kantoff Philip W, Finn Stephen, Vander Heiden Matthew G, Brown Myles, Giovannucci Edward L, Mucci Lorelei A

机构信息

Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, Florida.

出版信息

Cancer. 2017 Nov 1;123(21):4130-4138. doi: 10.1002/cncr.30831. Epub 2017 Jul 12.

Abstract

BACKGROUND

Obese men are at higher risk of advanced prostate cancer and cancer-specific mortality; however, the biology underlying this association remains unclear. This study examined gene expression profiles of prostate tissue to identify biological processes differentially expressed by obesity status and lethal prostate cancer.

METHODS

Gene expression profiling was performed on tumor (n = 402) and adjacent normal (n = 200) prostate tissue from participants in 2 prospective cohorts who had been diagnosed with prostate cancer from 1982 to 2005. Body mass index (BMI) was calculated from the questionnaire immediately preceding cancer diagnosis. Men were followed for metastases or prostate cancer-specific death (lethal disease) through 2011. Gene Ontology biological processes differentially expressed by BMI were identified using gene set enrichment analysis. Pathway scores were computed by averaging the signal intensities of member genes. Odds ratios (ORs) for lethal prostate cancer were estimated with logistic regression.

RESULTS

Among 402 men, 48% were healthy weight, 31% were overweight, and 21% were very overweight/obese. Fifteen gene sets were enriched in tumor tissue, but not normal tissue, of very overweight/obese men versus healthy-weight men; 5 of these were related to chromatin modification and remodeling (false-discovery rate < 0.25). Patients with high tumor expression of chromatin-related genes had worse clinical characteristics (Gleason grade > 7, 41% vs 17%; P = 2 × 10 ) and an increased risk of lethal disease that was independent of grade and stage (OR, 5.26; 95% confidence interval, 2.37-12.25).

CONCLUSIONS

This study improves our understanding of the biology of aggressive prostate cancer and identifies a potential mechanistic link between obesity and prostate cancer death that warrants further study. Cancer 2017;123:4130-4138. © 2017 American Cancer Society.

摘要

背景

肥胖男性患晚期前列腺癌及癌症特异性死亡的风险更高;然而,这种关联背后的生物学机制仍不清楚。本研究检测了前列腺组织的基因表达谱,以确定因肥胖状态和致命性前列腺癌而差异表达的生物学过程。

方法

对1982年至2005年被诊断为前列腺癌的2个前瞻性队列参与者的肿瘤(n = 402)和相邻正常前列腺组织(n = 200)进行基因表达谱分析。根据癌症诊断前立即填写的问卷计算体重指数(BMI)。对男性随访至2011年,观察有无转移或前列腺癌特异性死亡(致命性疾病)。使用基因集富集分析确定由BMI差异表达的基因本体生物学过程。通过对成员基因的信号强度求平均值来计算通路分数。用逻辑回归估计致命性前列腺癌的比值比(OR)。

结果

在402名男性中,48%体重正常,31%超重,21%非常超重/肥胖。与体重正常的男性相比,15个基因集在非常超重/肥胖男性的肿瘤组织而非正常组织中富集;其中5个与染色质修饰和重塑相关(错误发现率<0.25)。染色质相关基因肿瘤表达高的患者具有更差的临床特征( Gleason分级>7,41%对17%;P = 2×10),且致命性疾病风险增加,该风险独立于分级和分期(OR,5.26;95%置信区间,2.37 - 12.25)。

结论

本研究增进了我们对侵袭性前列腺癌生物学的理解,并确定了肥胖与前列腺癌死亡之间潜在的机制联系,值得进一步研究。《癌症》2017年;123:4130 - 4138。© 2017美国癌症协会。

相似文献

2
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Lancet Oncol. 2020 Feb;21(2):283-293. doi: 10.1016/S1470-2045(19)30797-1. Epub 2019 Dec 20.
3
Association of body mass index and prostate cancer mortality.
Obes Res Clin Pract. 2014 Jul-Aug;8(4):e374-81. doi: 10.1016/j.orcp.2013.06.002. Epub 2013 Aug 6.
4
Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Cancer Prev Res (Phila). 2021 Apr;14(4):463-470. doi: 10.1158/1940-6207.CAPR-20-0250. Epub 2020 Dec 22.
5
Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.
Int J Cancer. 2017 Sep 1;141(5):933-944. doi: 10.1002/ijc.30803. Epub 2017 Jun 8.
7
Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.
Cancer. 2017 Jun 15;123(12):2240-2247. doi: 10.1002/cncr.30580. Epub 2017 Jan 31.
8
Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
Urology. 2005 Jul;66(1):108-13. doi: 10.1016/j.urology.2005.01.060.
9
The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
J Urol. 2009 Feb;181(2):574-7; discussion 578. doi: 10.1016/j.juro.2008.10.028. Epub 2008 Dec 13.
10
The impact of obesity on overall and cancer specific survival in men with prostate cancer.
J Urol. 2009 Jul;182(1):112-7; discussion 117. doi: 10.1016/j.juro.2009.02.118. Epub 2009 May 17.

引用本文的文献

3
Epigenetic modifications in obesity-associated diseases.
MedComm (2020). 2024 Feb 24;5(2):e496. doi: 10.1002/mco2.496. eCollection 2024 Feb.
5
How Comorbidities Shape Cancer Biology and Survival.
Trends Cancer. 2021 Jun;7(6):488-495. doi: 10.1016/j.trecan.2020.12.010. Epub 2021 Jan 11.
7
Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.
Clin Cancer Res. 2020 Mar 1;26(5):1086-1093. doi: 10.1158/1078-0432.CCR-19-2853. Epub 2019 Nov 21.
9
-ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.
Clin Cancer Res. 2018 Nov 1;24(21):5471-5481. doi: 10.1158/1078-0432.CCR-18-1060. Epub 2018 Jul 16.
10
Regular aspirin use and gene expression profiles in prostate cancer patients.
Cancer Causes Control. 2018 Aug;29(8):775-784. doi: 10.1007/s10552-018-1049-5. Epub 2018 Jun 18.

本文引用的文献

1
Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.
Cancer. 2017 Jun 15;123(12):2240-2247. doi: 10.1002/cncr.30580. Epub 2017 Jan 31.
2
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches.
Oncogene. 2017 Jun 15;36(24):3359-3374. doi: 10.1038/onc.2016.485. Epub 2017 Jan 16.
3
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
J Mol Diagn. 2015 Jul;17(4):374-81. doi: 10.1016/j.jmoldx.2015.02.002. Epub 2015 Apr 30.
4
limma powers differential expression analyses for RNA-sequencing and microarray studies.
Nucleic Acids Res. 2015 Apr 20;43(7):e47. doi: 10.1093/nar/gkv007. Epub 2015 Jan 20.
5
Role of diet in prostate cancer: the epigenetic link.
Oncogene. 2015 Sep 3;34(36):4683-91. doi: 10.1038/onc.2014.422. Epub 2014 Dec 22.
6
Association of prostate cancer risk variants with gene expression in normal and tumor tissue.
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):255-60. doi: 10.1158/1055-9965.EPI-14-0694-T. Epub 2014 Nov 4.
7
Epigenetics and human obesity.
Int J Obes (Lond). 2015 Jan;39(1):85-97. doi: 10.1038/ijo.2014.34. Epub 2014 Feb 25.
8
Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG.
J Natl Cancer Inst. 2013 Dec 18;105(24):1881-90. doi: 10.1093/jnci/djt332. Epub 2013 Nov 30.
9
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host.
Nat Rev Cancer. 2013 Jul;13(7):497-510. doi: 10.1038/nrc3486. Epub 2013 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验